4//SEC Filing
Waddill William D. 4
Accession 0001104659-24-083039
CIK 0001377121other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 4:31 PM ET
Size
8.8 KB
Accession
0001104659-24-083039
Insider Transaction Report
Form 4
Waddill William D.
Director
Transactions
- Sale
Common Stock
2024-07-24$40.00/sh−8,000$320,000→ 12,000 total - Exercise/Conversion
Common Stock
2024-07-24$12.88/sh+8,000$103,040→ 20,000 total - Exercise/Conversion
Stock Option (right to buy)
2024-07-24−8,000→ 8,000 totalExercise: $12.88Exp: 2026-09-13→ Common Stock (8,000 underlying)
Footnotes (2)
- [F1]Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2023.
- [F2]These stock options are fully vested.
Documents
Issuer
Protagonist Therapeutics, Inc
CIK 0001377121
Entity typeother
Related Parties
1- filerCIK 0001553338
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 4:31 PM ET
- Size
- 8.8 KB